Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia

Gynecologic Oncology

Volumn 62, Issue 2, 1996, Pages 218-225

  Dellas, Athanassios ^a   Schultheiss, Elisabeth ^a   Almendral, Alfonso C ^a   Torhost, Joachim ^a   Gudat, Fred ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HERMES ANTIGEN; MONOCLONAL ANTIBODY; VIRUS DNA;

ANTIGEN EXPRESSION; ANTIGENIC VARIATION; ARTICLE; CANCER GRADING; CELL TRANSFORMATION; CONTROLLED STUDY; EXON; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 0030221339     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0219     Document Type: Article

References (20)

1. 1. Jalkanen, S., Bargatze, R. F., de-los-Toyos, J., and Butcher, E. C. Lymphocyte recognition of high endothelium: Antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells, J. Cell Biol. 105, 983-990 (1987).
2. 2. Ruiz, P., Schwärzler, C., and Günthert, U. CD44 isoforms during differentiation and development, BioEssays 17, 17 (1995).
3. 3. Günthert, U., Stauder, R., Mayer, B., Terpe, H.-J., Finke, L., and Friedrichs, K. Are CD44 variant isoforms involved in human tumour progression? Cancer Surv. 24, 19-42 (1995).
4. 4. Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zoller, M., Haussmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells, Cell 65, 13-24 (1991).
5. 5. Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., and Bell, J. I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons, Proc. Natl. Acad. Sci. USA 89, 12160-12164 (1992).
6. 6. Stauder, R., and Günthert, U. CD44 isoforms: Impact on lymphocyte activation and differentiation, Immunologist 3, 78-83 (1995).
7. 7. Fox, S. B., Gatter, K. C., Jackson, D. G., Screaton, G. R., Bell, M. V., Bell, J. I., Harris, A. L., Simmons, D., and Fawcett, J. CD44 and cancer screening, Lancet 342, 548-549 (1993).
8. 8. Joensuu, H., Klemi, P. J., Toikkanen, S., and Jalkanen, S. Glycoprotein CD44 expression and its association with survival in breast cancer, Am. J. Pathol. 143, 867-874 (1993).
9. 9. Mulder, J. W., Wielenga, V. J., Polak, M. M., van den Berg, F. M., Adolf, G. R., Herrlich, P., Pals, S. T., and Offerhaus, G. J. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis, Gut 36, 76-80 (1995).
10. 10. Wielenga, V. J. M., Heider, K. H., Offerhaus, J. A., Adolf, G. R., van den Berg, F. M., Ponta, H., Herrlich, P., and Pals, S. T. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression, Cancer Res. 53, 4754-4756 (1993).
11. 11. Fujita, N., Yaegashi, N., Ide, Y., Sato, S., Nakamura, M., Ishiwata, I., and Yajima, A. Expression of CD44 in normal human versus tumor endometrial tissues: Possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells, Cancer Res. 54, 3922-3928 (1994).
12. 12. Joensuu, H., Ristamaki, R., Klemi, P. J., and Jalkanen, S. Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma, Br. J. Cancer 68, 428-432 (1993).
13. 13. Friedrichs, K., Franke, F., Lisboa, B. W., Kugler, G., Gille, I., Terpe, H. J., Holzel, F., Maass, H., and Gunthert, U. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer, Cancer Res. 55, 5424-5433 (1995).
14. 14. Salmi, M., Grön-Virta, K., Sointu, P., Grenman, R., Kalimo, H., and Jalkanen, S. Regulated expression of exon v6 containing isoforms of CD44 in man: Downregulation during malignant transformation of tumors of squamocellular origin, J. Cell Biol. 122, 431-442 (1993).
15. 15. Terpe, H.-J., Stark, H., Prehm, P., and Günthert, U. CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues, Histochemistry 101, 79-89 (1994a).
16. 16. Dall, P., Heider, K.-H., Hekele, A., Minckwitz, G. v., Kaufmann, M., Ponta, H., and Herrlich, P. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium, Cancer Res. 54, 3337-3341 (1994).
17. 17. Kainz, C., Kohlberger, P., Sliutz, G., Tempfer, C., Heinzl, H., Reinthaller, A., Breitenecker, G., and Koelbl, H. Splice variants of CD44 in human cervical cancer stage IB to IIB, Gynecol Oncol. 57, 383-387 (1995).
18. 18. Reinthaller, A., Kainz, C., Kohlberger, P., Tempfer, C., Gitsch, G., Kolbl, H., and Breitenecker, G. CD44 splice variants as prognostic factors in invasive cervix carcinoma, Gynaekol Geburtshilfliche Rundsch. 35, 16-19 (1995).
19. 19. Lesley, J., Hyman, R., and Kincade, P. W. CD44 and its interaction with the extracellular matrix, Adv. Immunol. 54, 271-335 (1993).
20. 20. Aplin, J. D., Seif, M. W., Graham, R. A., Hey, N. A., Behzad, F., and Campbell, S. The endometrial cell surface and implantation - Expression of the polymorphic mucin MUC-1 and adhesion molecules during the endometrial cycle, in The human endometrium (C. Bulletti, E. Gurpide, and C. Flamigni, Eds.), 734, New York Acad. Sci., New York, pp. 103-121 (1994).